APA (7th ed.) Citation

Ross, P., Wasan, H., Croagh, D., Nikfarjam, M., Nguyen, N., Aghmesheh, M., . . . Harris, M. (2022). 1308P Comparison of tumour size on outcomes for patients with unresectable locally advanced pancreatic adenocarcinoma (LAPC) receiving P-32 microparticles with standard-of-care chemotherapy (SoC CT). Annals of Oncology, 33, S1142. https://doi.org/10.1016/j.annonc.2022.07.1440

Chicago Style (17th ed.) Citation

Ross, P., et al. "1308P Comparison of Tumour Size on Outcomes for Patients with Unresectable Locally Advanced Pancreatic Adenocarcinoma (LAPC) Receiving P-32 Microparticles with Standard-of-care Chemotherapy (SoC CT)." Annals of Oncology 33 (2022): S1142. https://doi.org/10.1016/j.annonc.2022.07.1440.

MLA (9th ed.) Citation

Ross, P., et al. "1308P Comparison of Tumour Size on Outcomes for Patients with Unresectable Locally Advanced Pancreatic Adenocarcinoma (LAPC) Receiving P-32 Microparticles with Standard-of-care Chemotherapy (SoC CT)." Annals of Oncology, vol. 33, 2022, p. S1142, https://doi.org/10.1016/j.annonc.2022.07.1440.